Syndivia Receives €2m Deeptech Financing From Bpifrance to Advance Its Lead Immunoconjugate for Solid Cancers syndivia.com/news/syndivia-r…
Syndivia retweeted
The October 16th issue of BC is now available. ow.ly/73hg50wMJbD Cover highlights review by Wagner Group @BFC_UMR7199 @BfcDovgan @sashakoniev pubs.acs.org/doi/10.1021/acs…
Our review on applications and synthesis of Antibody–Oligonucleotide Conjugates (AOC) is online! Check it on the Bioconjugate Chemistry website:
pubs.acs.org/doi/10.1021/acs…
Syndivia’s CSO, Dr Sergii Kolodych, will be speaking at #PEGS Boston 2019. Catch a glimpse of our latest developments in the field of native protein conjugation on April 11 at Seaport World Trade Center, Boston, MA.
Syndivia retweeted
France Tech Transfer: 12 startups sélectionnées pour participer au European Venture Summit à Düsseldorf bit.ly/2kbhywe @bymaddyness
Syndivia retweeted
Tout notre soutien aux projets @syndivia, @LMB_GlioCure et @Phostin accompagnés par @MATWIN_Bdx ! nitter.gq/ReseauSATT/status/8267…
Tout est prêt pour le France Tech Transfert Invest : Aujourd'hui coaching pour les 40 start-ups @ReseauSATT @Bpifrance @Tech_Tour
Syndivia retweeted
@ConectusAlsace & @syndivia signent une licence exclusive sur une technologie originale dans le traitement du cancer bit.ly/2gBbeeT
Syndivia retweeted
@ConectusAlsace & @syndivia signent une licence exclusive sur une technologie originale dans le traitement du cancer bit.ly/2gBbeeT
OGD2 Pharma and Syndivia launch collaboration to develop an ADC targeting the O-acetyl-GD2 cancer antigen
bit.ly/2c2QQNO
Syndivia receives the EU’s Horizon 2020 grant for the development of next-generation targeted cancer therapies
bit.ly/2aLeY9H
Syndivia signs distribution agreement with Sigma-Aldrich bit.ly/1WcqSbE
Meet us at the SMi's annual ADC Summit, 23-24 May, London bit.ly/1TjP0d0
Syndivia is hiring a Research Associate in cell biology. For more details visit: bit.ly/1FRIAbI
Syndivia introduces a new route for the preparation of Antibody-Drug Conjugates in its recent scientific article : bit.ly/1VBiZNe
Syndivia lands €275k grant to develop next-generation Antibody-Drug Conjugates bit.ly/1MhyUwZ
Syndivia is among the TOP100 startups of the Hello Tomorrow Challenge bit.ly/1KxrOVB
Syndivia retweeted
It’s about to start #HTC2015 – at Seine-Saint-Denis, Ile-de-France
A thorough review, published by Syndivia's co-founders, outlines recent advances in the field of bioconjugation rsc.li/1Hzelvc















